Clinical Trials on Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal Carcinoma in Spain
Total 97 results
-
Grupo Espanol Multidisciplinario del Cancer DigestivoCompletedAdvanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment)Spain
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Korea, Republic of, China, Spain, Taiwan, Japan, Argentina, Canada, Croatia, Greece, Ireland, Malaysia, Netherlands, Portugal, Romania, Thailand, Turkey, United Kingdom
-
Astellas Pharma Global Development, Inc.Active, not recruitingLocally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer | Metastatic Gastric Adenocarcinoma or Cancer | Metastatic Gastroesophageal Junction (GEJ) AdenocarcinomaUnited States, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, France, Germany, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Spain, Taiwan, United Kingdom
-
Hoffmann-La RocheBioLineRx, Ltd.; Halozyme TherapeuticsActive, not recruitingGastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma or Esophageal CarcinomaUnited States, United Kingdom, Australia, Korea, Republic of, Taiwan, Israel, Spain
-
BeiGeneActive, not recruitingGastric, or Gastroesophageal Junction AdenocarcinomaUnited States, China, Spain, Korea, Republic of, Poland, Russian Federation, Taiwan, France, Turkey, Japan, Italy, United Kingdom, Puerto Rico
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third LineSpain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
-
Bristol-Myers SquibbCompletedLocally Advanced (Unresectable) or Metastatic Adenocarcinoma of the Gastric and Gastro-esophageal JunctionFrance, Poland, Russian Federation, Taiwan, United States, Hong Kong, Spain, Germany, Italy, Japan, Korea, Republic of, Singapore
-
AmgenTerminatedGastric and Gastroesophageal Junction AdenocarcinomaKorea, Republic of, Taiwan, Spain, Austria, United States, France, Japan, Germany, Netherlands
-
Grupo Gallego de Investigaciones OncologicasAmgen; Trial Form Support S.L.UnknownGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaSpain
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingGastric Cancer | Esophageal Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Argentina, Australia, Brazil, Canada, Chile, China, Colombia, Czechia, France, Germany, Greece, Hong Kong, Hungary, Israel, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Portugal, Romania, Russian Federation, Si... and more
-
Millennium Pharmaceuticals, Inc.TerminatedAdvanced and Metastatic Gastric or Gastroesophageal AdenocarcinomaUnited States, Spain
-
Eli Lilly and CompanyCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaItaly, United States, Spain, Ukraine, Germany, Greece, Czechia, Turkey, Belgium, Sweden, Canada
-
ALX Oncology Inc.Eli Lilly and CompanyRecruitingGastric Cancer | Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, France, Korea, Republic of, Taiwan, United Kingdom, Japan, Singapore, Belgium, Czechia, Italy
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal JunctionUnited States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
-
Gilead SciencesCompletedGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaSpain, United States, Hungary, United Kingdom, Italy, France, Poland, Australia, Belgium
-
Eli Lilly and CompanyCompletedMetastatic Gastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaGermany, Italy, Spain, United States, Hungary, Russian Federation, Poland, Belgium, Netherlands, France, Czechia, Mexico, Argentina, Canada, Denmark, Finland, Israel, Japan, Puerto Rico, United Kingdom
-
Daiichi SankyoAstraZenecaRecruitingGastroesophageal Junction Adenocarcinoma | Gastric Cancer, AdenocarcinomaHong Kong, Korea, Republic of, France, United Kingdom, Spain, China, Ireland, Brazil, Japan, Singapore, Belgium, Israel, Russian Federation, Argentina, Chile, Hungary, Poland, Portugal, Taiwan, Turkey, Ukraine, Germany, Romania, Italy
-
AstraZenecaTerminatedMetastatic, Gastric or Gastro-oesophageal Junction, CancerKorea, Republic of, Spain, Taiwan, Germany, Japan
-
Merck Sharp & Dohme LLCActive, not recruitingGastric Neoplasms | Gastroesophageal Junction AdenocarcinomaUnited States, Australia, Brazil, Chile, China, France, Germany, Guatemala, Ireland, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaKorea, Republic of, United States, Israel, Italy, Spain, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Japan, Taiwan, China, Belgium, Poland, Thailand, Czechia, Singapore, Hungary, Argentina, Brazil, Romania, Portuga... and more
-
AmgenZai Lab (China only)RecruitingGastric Cancer | Gastroesophageal Junction AdenocarcinomaCanada, Japan, United States, Korea, Republic of, China, Italy, Australia, Sweden, Spain, Taiwan, France, Belgium, Denmark, Thailand, Turkey, Czechia, Bulgaria, Brazil, Norway, Mexico, Poland, Estonia, Israel, Greece, Romania, Chile, Peru, Po... and more
-
BioInvent International ABActive, not recruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric Adenocarcinoma | Metastatic Gastroesophageal Junction Adenocarcinoma | HER2-positive Metastatic Breast CancerSpain, United Kingdom, Germany
-
Jazz PharmaceuticalsBeiGene, Ltd.RecruitingGastroesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Gastric NeoplasmsKorea, Republic of, Belgium, Japan, China, Netherlands, Spain, Germany, United Kingdom, Malaysia, Portugal, France, Italy, Australia, Taiwan, Turkey, Thailand, Argentina, Mexico, Ireland, Estonia, Serbia, Romania, Canada, Poland, Brazil, ... and more
-
SanofiActive, not recruitingAdenocarcinoma Gastric | Gastrooesophageal CancerJapan, Belgium, Korea, Republic of, Spain, Russian Federation, Turkey
-
AstraZenecaRecruitingGastric Cancer | Pancreatic Adenocarcinoma | Gastroesophageal Junction CancerUnited States, Spain, United Kingdom, Korea, Republic of, Canada, Japan, Malaysia, Taiwan, Singapore, Moldova, Republic of, Australia, Poland, Georgia
-
Eli Lilly and CompanyAstraZenecaCompletedHepatocellular Carcinoma | Gastric Cancer | Non-Small Cell Lung Cancer | Gastroesophageal Junction AdenocarcinomaUnited States, Spain, Korea, Republic of, Taiwan, Germany, Italy, France, Israel
-
Millennium Pharmaceuticals, Inc.TerminatedAdenocarcinoma of the Stomach | Gastroesophageal Junction Expressing Guanylyl Cyclase CUnited States, Belgium, Spain, United Kingdom
-
SanofiMerck Sharp & Dohme LLCActive, not recruitingHepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Oesophageal Adenocarcinoma | Oesophageal Squamous Cell CarcinomaKorea, Republic of, Belgium, Italy, United States, Chile, China, France, Netherlands, Spain
-
Vall d'Hebron Institute of OncologyActive, not recruitingStomach Neoplasms | Gastroesophageal Junction AdenocarcinomaSpain
-
AstraZenecaRecruitingGastric Cancer | Gastroesophageal Junction CancerCanada, Spain, United Kingdom, China, France, Italy, Vietnam, Germany, United States, India, Taiwan, Thailand, Hong Kong, Japan, Switzerland, Poland
-
Eli Lilly and CompanyMerck Sharp & Dohme LLCCompletedCarcinoma, Transitional Cell | Gastric Adenocarcinoma | Non-small Cell Lung Cancer | Biliary Tract Cancer | Adenocarcinoma of the Gastroesophageal JunctionGermany, United States, Spain, United Kingdom, France, Japan
-
Spanish Cooperative Group for the Treatment of...Sanofi; Hoffmann-La RocheCompleted
-
Taiho Oncology, Inc.TerminatedMetastatic Diffuse Gastric Cancer Including Carcinoma of the Gastro-esophageal JunctionBelgium, Spain, United States, Italy, Estonia, Russian Federation, Bulgaria, Hungary, Croatia, Israel, Mexico, Poland, Portugal, Romania, South Africa, Ukraine, United Kingdom, Brazil, Germany, Argentina
-
Bristol-Myers SquibbWithdrawnStomach Cancer | Gastric Cancer | Cancer of the Stomach | Gastroesophageal JunctionBrazil, Italy, United States, Argentina, Chile, Germany, Spain, Australia, Canada, Portugal, Mexico, Romania, Colombia, Puerto Rico
-
European Organisation for Research and Treatment...Active, not recruitingGastric and Esophagogastric Junction AdenocarcinomaUnited Kingdom, Italy, France, Spain, Germany, Czechia, Israel, Norway, Poland
-
Neovii BiotechCompletedGastric Cancer | Gastric AdenocarcinomaAustria, Spain, United Kingdom, Germany
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingAdvanced/Metastatic Gastroesophageal AdenocarcinomaChina, Japan, Poland, Hong Kong, Korea, Republic of, Canada, United States, Argentina, Australia, Belgium, Chile, Colombia, Costa Rica, France, Germany, Guatemala, Ireland, Israel, Italy, Russian Federation, Spain, Taiwan, Turkey, United...
-
Taiho Oncology, Inc.RecruitingPancreatic Cancer | Esophageal Adenocarcinoma | Esophageal Squamous Cell Cancer | Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer | Siewert Type 1 GEJ CancerUnited States, Spain, Germany, France
-
Taiho Oncology, Inc.Active, not recruitingAdvanced or Metastatic Solid Tumor | Advanced or Metastatic Gastric or Gastroesophageal Cancer | Myeloid or Lymphoid Neoplasms (MLN)United States, Spain, Turkey, Hong Kong, Korea, Republic of, Belgium, Japan, Netherlands, France, Germany, Italy, Sweden, United Kingdom, Portugal, Singapore
-
Basilea PharmaceuticaTerminatedGastric AdenocarcinomaSpain, United States, Korea, Republic of, Belgium, Russian Federation, United Kingdom, Italy, France, Turkey, Germany, Poland, Brazil, Australia, Argentina, Chile
-
Daiichi SankyoAstraZenecaCompletedAdenocarcinoma Gastric Stage IV With Metastases | Adenocarcinoma - GEJUnited States, Spain, Belgium, Italy, United Kingdom
-
Gilead SciencesCompletedGastric AdenocarcinomaSpain, United States, United Kingdom, Turkey, France, Germany, Chile, Australia, Colombia, Czechia, Belgium, Hungary, Italy, Peru, Poland, Romania
-
SOLTI Breast Cancer Research GroupNovartisRecruitingMelanoma | Sarcoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Pancreatic Adenocarcinoma | Uterine Carcinosarcoma | Mesothelioma | Cholangiocarcinoma | Lung Adenocarcinoma | Triple Negative Breast Cancer | Epithelial Ovarian Cancer | HER2-positive Breast Cancer | Head and Neck Squamous Cell Carcinoma | Esophageal... and other conditionsSpain
-
Hospices Civils de LyonActive, not recruitingGastric AdenocarcinomaSpain, France
-
Novartis PharmaceuticalsRecruitingGlioblastoma Multiforme | Gastroesophageal Adenocarcinoma | Pancreatic Ductal AdenocarcinomaNetherlands, Spain, Israel, United States, Switzerland
-
Shattuck Labs, Inc.CompletedMelanoma | Renal Cell Carcinoma | Hodgkin Lymphoma | Gastric Adenocarcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and Neck | Diffuse Large B Cell Lymphoma | Urothelial Carcinoma | Gastroesophageal Junction Adenocarcinoma | Squamous Cell Carcinoma of the Skin | Squamous Cell Carcinoma... and other conditionsUnited States, Canada, Belgium, Spain
-
Bristol-Myers SquibbRecruitingMelanoma | Carcinoma, Renal Cell | Cervical Cancer | Pancreatic Adenocarcinoma | Ovarian Neoplasms | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Neoplasms | Urothelial Carcinoma | Microsatellite Stable Colorectal Cancer | Non-Small-Cell Lung Cancer | Gastric/Gastroesophageal Junction...United States, Australia, Italy, Germany, Spain, Canada, Israel, Japan
-
Seagen Inc.RecruitingUterine Cervical Neoplasms | Stomach Neoplasms | Urinary Bladder Neoplasms | Ovarian Neoplasms | Squamous Cell Carcinoma of Head and Neck | Carcinoma, Non-Small Cell Lung | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction Adenocarcinoma | HER2 Negative Breast Neoplasms and other conditionsUnited States, Spain, United Kingdom, France, Switzerland
-
AstraZenecaRecruitingGastric CancerSpain, China, Korea, Republic of, United States, Taiwan, Japan, United Kingdom
-
IpsenCompletedMetastatic Renal Cell Cancer | Advanced or Metastatic Hepatocellular Cancer | Advanced or Metastatic Ovarian Cancer | Advanced or Metastatic Gastric CarcinomaBelgium, Canada, France, Spain, United Kingdom